![]() |
市場調查報告書
商品編碼
1389701
支鏈胺基酸(BCAA) 市場規模- 按類型(L-亮氨酸、L-異亮氨酸和L-纈氨酸)、應用(運動營養、食品和飲料、動物飼料、藥品、化妝品和個人護理)、形式與全球預測,2023 - 2032Branched Chain Amino Acids (BCAAs) Market Size - By Type (L-Leucine, L-Isoleucine, and L-Valine), Applications (Sports Nutrition, Food and Beverage, Animal Feed, Pharmaceuticals, Cosmetics and Personal Care), Form & Global Forecast, 2023 - 2032 |
由於電子商務通路日益佔據主導地位,可以輕鬆線上獲取各種產品,全球支鏈氨基酸 (BCAA) 市場規模預計在 2023 年至 2032 年期間CAGR為 5.8%。
為了滿足不同的喜好並增強消費者的整體體驗,一些支鏈胺基酸供應商正在專注於創新,推出新的配方和口味。對引入新的輸送形式(例如粉末、膠囊和飲料)的大力重視也將促進市場的成長。舉個例子,2021 年 10 月,英國快速成長的運動營養品牌 Applied Nutrition 推出了新系列 BCAA 胺基酸水合物飲料,裝在 330 毫升碳酸罐中,以擴大其隨身攜帶系列。
整個支鏈胺基酸產業根據類型、形式、應用和地區進行細分。
就類型而言,2023-2032年L-纈氨酸市場規模的CAGR可能為6.3%。 L-纈氨酸天然存在於多種富含蛋白質的食物中,例如肉類、乳製品和豆類。為此,它被廣泛用作膳食補充劑,與其他支鏈氨基酸結合使用,以滿足蛋白質需求增加和特定健身目標的個人。肝功能調節以及傷口癒合和組織修復的重要性日益提高也將有利於產品需求。
根據應用,到 2032 年,製藥領域的支鏈胺基酸市場規模預計將以 6.4% 的成長率擴大。這可以歸因於藥物配方中的支鏈胺基酸含量不斷增加,為面臨挑戰的患者提供營養支持。透過定期飲食攝取充足的蛋白質。隨著癌症和慢性阻塞性肺病 (COPD) 等慢性疾病負擔的日益加重,蛋白質合成中對支鏈氨基酸(尤其是亮氨酸)的需求不斷增加,以幫助維持肌肉量。
從地區來看,由於健康和健身意識不斷增強以及對運動營養的強烈關注,歐洲支鏈氨基酸行業規模預計從 2023 年到 2032 年將以 5.8% 的CAGR成長。
植物性產品的新興趨勢推動了植物性飲食的日益普及,推動了對源自豌豆、大豆和其他植物性蛋白質的植物性支鏈胺基酸的需求不斷成長。多個電子商務平台的便利性和廣泛的產品選擇也將有助於區域產品的吸收。
Global Branched Chain Amino Acids (BCAAs) Market size is poised to record 5.8% CAGR from 2023-2032, due to the growing dominance of e-commerce channels to render ease of access to wide range of products online.
To match the diverse preferences and enhance the overall experiences of consumers, several BCAA providers are focusing on innovations for introducing new formulations and flavors. The robust emphasis on introducing new delivery formats, such as powders, capsules, and drinks will also compliment the market growth. To cite an instance, in October 2021, the U.K.-based fast-growing sports nutrition brand Applied Nutrition introduced a new line of its BCAA amino-hydrate drinks in a 330ml carbonated can for expanding its On-the-go range.
The overall BCAAs industry is segmented based on type, form, application, and region.
In terms of type, the market size from the L-valine segment may observe 6.3% CAGR from 2023-2032. L-valine is naturally found in several protein-rich foods, such as meat, dairy products, and legumes. To that end, it is widely used as a dietary supplement in combination with other BCAAs to cater to individuals with increased protein needs and specific fitness goals. Rising importance in the regulation of liver function as well as wound healing and tissue repair will also prove favorable for the product demand.
On the basis of application, the branched chain amino acids market size from the pharmaceuticals segment is expected to expand at 6.4% growth rate up to 2032. This can be ascribed to the rising inclusion in pharmaceutical formulations to provide nutritional support for patients facing challenges in consuming adequate protein through regular dietary intake. With the growing burden of chronic illnesses, such as cancer and chronic obstructive pulmonary disease (COPD), the demand for BCAAs, especially leucine is increasing in protein synthesis to help preserve muscle mass.
Regionally, the Europe BCAAs industry size is projected to accrue 5.8% CAGR from 2023 to 2032 due to the increasing awareness of health and fitness along with the strong focus on sports nutrition.
The growing popularity of plant-based diets driven by the emerging trend of plant-based products is pushing the increasing demand for plant-based BCAAs sourced from peas, soy and other plant proteins. The ease of access to convenience and wide range of product choices in multiple e-commerce platforms will also contribute to the regional product uptake.